Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ETRA-SWITCH: Switching Protease Inhibitor to Etravirine in Virologically Suppressed HIV-1 Patients
NCT01034917Phase 3Completed
- Sponsor
- Hospital Universitari Germans Trias i Pujol
- Start
- Dec 2009
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of etravirine in human immunodeficiency virus infection (HIV), sponsored by Hospital Universitari Germans Trias i Pujol. Started Dec 2009; status: completed.
02
Drugs
etravirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01034917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01034917.